Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course azithromycin for mild to moderate pelvic inflammatory disease
2010-023254-36Phase 4Terminated
- Sponsor
- Brighton and Sussex University Hospitals NHS Trust
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of azithromycin in Pelviabdominal infection, sponsored by Brighton and Sussex University Hospitals NHS Trust. Primary endpoint: Clinical efficacy: reduction in pelvic tenderness at day 14–21. Started May 2011; status: terminated.
02
Drugs
azithromycin
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on 2010-023254-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023254-36.